Want to join the conversation?
In 3Q15, $BXLT reported earnings on a GAAP basis of $309MM & $0.45 per diluted share including net after-tax special items of $76MM, or $0.11 per share. On an adjusted pro forma basis, excluding special items, $BXLT reported earnings of $385MM & $0.56 per diluted share, exceeding its previously-issued guidance of $0.48-0.50 per diluted share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?